LFA
IDXX icon

LGT Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

LGT Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$536 – 507
2025
Q2 		$536 Buy
+1
New +$478 ﹤0.01% 427
2025
Q1 		– Sell
-32
Closed -$13.2K – 507
2024
Q4 		$13.2K Hold
32
– – 0.03% 390
2024
Q3 		$16.2K Hold
32
– – 0.04% 321
2024
Q2 		$15.6K Hold
32
– – 0.03% 368
2024
Q1 		$17.3K Hold
32
– – 0.02% 387
2023
Q4 		$17.8K Hold
32
– – 0.02% 378
2023
Q3 		$14K Buy
+32
New +$16K 0.02% 417

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

LGT Financial Advisors's IDXX Position: Q3 2025 in Review

LGT Financial Advisors sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 1 share — an estimated $536 sold.

LGT Financial Advisors first reported a position in IDXX in Q3 2023 and held it in 7 quarters. The position peaked at $17.8K in Q4 2023. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • LGT Financial Advisors reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 1 Idexx Laboratories share in Q3 2025, an estimated $536.
  • LGT Financial Advisors first reported a position in Idexx Laboratories in Q3 2023 and held it in 7 quarters.
  • LGT Financial Advisors's Idexx Laboratories position peaked at $17.8K in Q4 2023.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.